SMTL ID : 9giq.1

BFL1 covalently bound to inhibitor compound 13

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.42 Å

Oligo State

monomer

Ligands

1 x BUD: (2S,3S)-butane-2,3-diol(Non-covalent)

BUD.1: 4 residues within 4Å: Chain A: E.50, L.57, I.99, K.103 3 PLIP interactions: 3 interactions with chain A Hydrophobic interactions: A:I.99, A:K.103 Water bridges: A:D.58

1 x 01: ~{N}-[4-[(1~{R},3~{R})-3-azanylcyclopentyl]oxyphenyl]-~{N}-[(1~{S})-1-(4-chlorophenyl)-3-methyl-3-oxidanyl-butyl]propanamide

01.2: 10 residues within 4Å: Chain A: V.49, L.53, C.56, L.57, V.60, V.75, E.79, T.92, F.96, K.103 10 PLIP interactions: 10 interactions with chain A Hydrophobic interactions: A:V.49, A:L.53, A:L.57, A:V.60, A:V.75, A:V.75, A:T.92, A:F.96, A:F.96 Water bridges: A:E.79

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Palisse, A. et al., Structure-Based Discovery of a Series of Covalent, Orally Bioavailable, and Selective BFL1 Inhibitors. J.Med.Chem. (2024)

Release Date

2024-12-18

Peptides

Bcl-2-related protein A1: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Bcl-2-related protein A1

Related Entries With Identical Sequence